2018 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019
Contents:
- Executive Summary - pp. 2-6 (5 pages)
- Laboratory Report -– pp. 7-34 (28 pages)
- Sport Report - pp. 35-159 (125 pages)
- Testing Authority Report - pp. 160-304 (145 pages)
- ABP Report-Blood Analysis - pp. 305-343 (39 pages)
2019 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
Contents:
Report Highlights
The World Anti-Doping Agency (WADA) has published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.
This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).
2020 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021
Contents:
Report Highlights:
The World Anti-Doping Agency (WADA) has publishes its 2020 Testing Figures Report (2020 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2020.
This is the sixth and last set of global testing figures under the 2015 World Anti-Doping Code (Code) that came into effect in January 2015. The 2020 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
2021 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023
Contents:
Report Highlights:
The World Anti-Doping Agency (WADA) has publishes its 2021 Testing Figures Report (2021 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2021.
This is the first set of global testing figures under the 2021 World Anti-Doping Code (Code) that came into effect in January 2021. The 2021 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
2022 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2024
Contents:
Report Highlights:
A 6.4% increase in the total number of samples (including urine, non-ABP blood and dried blood spot samples) analyzed and reported into ADAMS in 2022 (256,770) vs. 2021 (241,430);
An increase in the total percentage of AAFs year on year;
An increase in the total number of samples analyzed and reported by most WADA-accredited laboratories and WADA-approved laboratories into ADAMS in 2022 vs 2021.
An increase in the total number and percentage of non-ABP blood and DBS samples analyzed in 2022.
An increase of 1.4% in the number of ABP blood samples analyzed in 2022.
An increase in the total number of AAFs and % AAF for ERAs [including erythropoietin (EPO) and other EPO-receptor agonists], GHRFs and GC/C/IRMS tests in 2022.
The World Anti-Doping Agency (WADA) has published its 2022 Testing Figures Report (2022 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2022.
The 2022 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
Independent Observers Report of the XXIII Olympic Winter Games Pyeongchang 2018 / McDevitt, Ben. - Independent Observer Team. - Montreal : World Anti-Doping Agency (WADA), 2018
Noitice - Meldonium / World Anti-Doping Agency (WADA). - 2016
A. Inclusion on the Prohibited List and excretions studies
B. Results management and adjudication
1. Results management shall proceed
2. Results management may be stayed
3. Cases where the concentration is below 1 μg/ml and the test was taken before 1 March 2016
Notice - Meldonium / World Anti-Doping Agency (WADA). - 2016
An updated guidance regarding the results management and adjudication process to be followed for cases involving meldonium.
- Urine Collection Date: from 1 January to 29 February 2016
- Urine Collection Date: from 1 March to 30 September 2016
- Urine Collection Date: after 30 September 2016
